MCED Test Performance in Obese Individuals

This abstract evaluates a multi-cancer early detection (MCED) blood test specifically designed for individuals with obesity, a group at higher risk for several cancers often without standard screening. The study investigated the test’s ability to accurately detect cancer and identify the tissue of origin using a two-step methylation profiling method. Results showed the test had a high positive predictive value (PPV) and reasonable sensitivity, […]

The role of GLP-1 receptor agonists in the management of obesity

As Australia faces a turning point in obesity management, researchers from Monash University have contributed new insights into the rapidly evolving use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as Ozempic in the Australian health care system.

GLP-1 drugs are life-changing — let’s remove their stigma

I have struggled with my weight my entire life — sometimes less successfully (hello, cooking school in Paris) and sometimes much more successfully. Prior to becoming pregnant, I can’t remember a single time in my life that I wasn’t on a diet or some special workout kick, or whatever it might be. This led me […]

Study compares Zepbound and Wegovy for weight loss in direct comparison

Weight-loss medications continue to grow in popularity as an anti-obesity tool — but are some more effective than others? The question was explored in a new study published this month in The New England Journal of Medicine. Researchers compared the safety and efficacy of tirzepatide (brand name Zepbound) and semaglutide (brand name Wegovy) in a […]